Provided by Tiger Trade Technology Pte. Ltd.

Rhythm Pharmaceuticals Inc.

111.44
+1.441.31%
Post-market: 111.440.00000.00%19:30 EDT
Volume:400.56K
Turnover:44.60M
Market Cap:7.67B
PE:-35.75
High:113.60
Open:112.29
Low:109.89
Close:110.00
52wk High:122.20
52wk Low:74.50
Shares:68.85M
Float Shares:65.39M
Volume Ratio:0.76
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1172
EPS(LYR):-3.1100
ROE:-117.04%
ROA:-30.96%
PB:74.51
PE(LYR):-35.83

Loading ...

Rhythm Says New Late-Stage Data for Obesity Drug Shows Strong Weight Loss, Hunger Reduction

MT Newswires Live
·
Mar 02

Rhythm Pharmaceuticals price target lowered to $140 from $141 at Canaccord

TIPRANKS
·
Mar 02

Rhythm Pharmaceuticals Nears Key FDA Calls With Global Growth Potential

Simply Wall St.
·
Mar 02

Rhythm announces additional data from Phase 3 trial of setmelanotide

TIPRANKS
·
Mar 02

BRIEF-Rhythm Pharmaceuticals Says PDUFA Goal Date For Setmelanotide Is March 20, 2026

Reuters
·
Mar 02

Rhythm Pharmaceuticals reports positive Phase 3 TRANSCEND data for setmelanotide in acquired hypothalamic obesity

Reuters
·
Mar 02

Rhythm Pharmaceuticals Announces Additional Positive Data From Phase 3 Transcend Trial of Setmelanotide in Patients With Acquired Hypothalamic Obesity

THOMSON REUTERS
·
Mar 02

Rhythm Pharmaceuticals Inc - Primary Endpoint Achieved With 16.4% Bmi Reduction

THOMSON REUTERS
·
Mar 02

Rhythm Pharmaceuticals Inc - Pdufa Goal Date for Setmelanotide Is March 20, 2026

THOMSON REUTERS
·
Mar 02

Rhythm Pharmaceuticals (RYTM) Receives a Buy from Jefferies

TIPRANKS
·
Feb 28

Stock Track | Rhythm Pharmaceuticals Plummets 5.30% Intraday Following Analyst Target Price Cuts

Stock Track
·
Feb 27

Rhythm Pharmaceuticals Analysts Raise Their Forecasts After Upbeat Q4 Results

Benzinga_recent_news
·
Feb 27

Rhythm Pharmaceuticals price target lowered to $136 from $145 at Wells Fargo

TIPRANKS
·
Feb 27

Rhythm Pharmaceuticals price target raised to $176 from $167 at Citizens

TIPRANKS
·
Feb 27

Rhythm Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Feb 27

U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler

Reuters
·
Feb 27

BRIEF-Rhythm Pharmaceuticals Files For Mixed Shelf

Reuters
·
Feb 27

Rhythm Pharmaceuticals files automatic mixed securities shelf

TIPRANKS
·
Feb 27

Rhythm Pharmaceuticals files to sell 2.4M shares of common stock for holders

TIPRANKS
·
Feb 27

Rhythm Pharmaceuticals Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Feb 27